Medicure (MCUJF) Net Cash Flow Growth (3y) (2013 - 2026)
Medicure (MCUJF) Net Cash Flow Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 32.03% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 28.99% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 37.89% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -49.94% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 37.74% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -41.05% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -62.71% |
| 10 | Medicure | 8.77 Mn | 7.64 Mn | 2.57 Mn | -226.04% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -226.04% |
| Sep 30, 2025 | -39.24% |
| Jun 30, 2025 | -58.80% |
| Mar 31, 2025 | 26.53% |
| Sep 30, 2024 | -51.82% |
| Jun 30, 2024 | -29.77% |
| Mar 31, 2024 | -58.46% |
| Dec 31, 2023 | 33.64% |
| Sep 30, 2023 | -35.86% |
| Jun 30, 2023 | 36.63% |
| Mar 31, 2023 | 27.74% |
| Sep 30, 2022 | 30.04% |
| Jun 30, 2022 | 29.08% |
| Mar 31, 2022 | 59.88% |
| Sep 30, 2021 | -50.79% |
| Jun 30, 2021 | 31.39% |
| Mar 31, 2021 | -35.17% |
| Sep 30, 2020 | -69.95% |
| Jun 30, 2020 | 50.73% |
| Mar 31, 2020 | 22.67% |